Dr James Taylor, Senior Scientist in Cell Line Development at Samsung Biologics, speaks with DDW’s Megan Thomas about how to address the challenges in meeting complex molecule requirements, regulatory standards, and environmental sustainability. Benefits for developers The biopharmaceutical industry has seen a surge in demand for drugs that treat conditions such as cancer, autoimmune diseases, […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!